MétaCan
Menu
Back to cohort
Record W2087292186 · doi:10.1016/j.jalz.2012.05.2088

P3‐414: Evaluation of a novel caspase‐6 inhibitor as a potential treatment for Alzheimer's disease

2012· article· en· W2087292186 on OpenAlexaff
Prateep Pakavathkumar, Jan‐Eric Ahlfors, Andréa C. LeBlanc

Bibliographic record

VenueAlzheimer s & Dementia · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMachine Learning in Bioinformatics
Canadian institutionsNew World LaboratoriesMcGill University
Fundersnot available
KeywordsCaspaseCaspase 3Molecular biologyPharmacologyCell cultureApoptosisCaspase-9Recombinant DNABiologyChemistryBiochemistryProgrammed cell deathGenetics

Abstract

fetched live from OpenAlex

Caspase-6 activity is found abundantly in the neuropil threads, neuritic plaques and neurofibrillary tangles of familial and sporadic forms of Alzheimer disease. Caspase-6 induces axonal degeneration and memory impairment in mice (abstract submitted at this meeting). Therefore, inhibiting Caspase-6 represents a potential treatment for Alzheimer disease. Unfortunately, there are no known natural inhibitors of Caspase-6. In this study, we investigated a newly developed irreversible Caspase-6 inhibitor called NWL-117 developed by New World Laboratories. The toxicity of the Caspase-6 inhibitor was verified on the HCT116 cell line and human primary neurons by MTT, propidium iodide FACS analyses, and Caspase-3 processing by western blots or activity by fluorogenic assays. Dose-dependent inhibition of Caspase-6 was assessed by in vitro fluorogenic assays with purified recombinant active Caspase-6 and on HCT116 cells transfected with a self-activating form of Caspase-6. Inhibition of active Caspase-6 was also assessed in primary human neurons in culture. Caspase-6 activity in cellulo was assessed with FLICA TM -Caspase-6 assays. Specificity of the NWL-117 inhibitor for Caspase-6 was investigated by conducting dose response curves on other purified recombinant caspases by fluorogenic assays. The NWL-117 was not toxic to the HCT116 cells or the neurons at 20 to 100 μM concentrations. In vitro, a dose dependent inhibition of recombinant active Caspase-6 was observed between 50 nM (50%) and 5 μM (100%). NWL-117 was more potent than the peptide inhibitor, Ac-VEID-fmk. A 1 μM concentration of NWL-117 inhibited almost 50% of active Caspase-6 in HCT116 cells and showed a dose-dependent inhibition between 5 μM and 100 μM concentrations. Western blot analyses showed that the Caspase-6 was processed into its active form in the absence or presence of the inhibitor. These results show that NWL-117 is cell permeable and non-toxic at high concentrations. NWL-117 is a potent inhibitor of the processed active form of Caspase-6. Therefore, the NWL-117 can be used to assess if Caspase-6-mediated axonal degeneration can be inhibited and possibly reversed in primary human neurons and mouse brains. If so, this compound is an interesting “lead” compound to develop as an inhibitor of Caspase-6 in Alzheimer disease patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.328
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicMachine Learning in BioinformaticsFrench-language works237,207